retatrutide expanded access compassionate use eli lilly Eli Lilly's Phase 3 data is in on Retatrutide! Here's what they found:

Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In

27.76

★★★★☆4.8 (126)

Eli Lilly drug delivers strong weight loss and arthritis pain relief results

29.08

★★★★★4.9 (98)

Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get them

22.58

★★★★★5.0 (157)

Eli Lilly's retatrutide is still in clinical trials. But gym bros are already using a version of the weight-loss drug, amid a growing DIY culture in fitness circles. (Credit: Courtesy of Max

22.74

★★★★★4.7 (84)

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

21.62

★★★★★4.9 (203)

Eli Lilly retatrutide Phase 3 obesity trial results 2026

28.29

★★★★★5.0 (176)

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

23.69

★★★★★4.8 (132)